Table 2.

Characteristics of the patients.

	Total N = 103	OCS N = 87	SCS N = 16	p value
Age	60 (51–67)	60 (51–67)	63 (55–67)	0.51
Current tumor
Primary	74 (71.8%)	63 (72.4%)	11 (68.8%)	0.76
Recurrent	29 (28.2%)	24 (27.6%)	5 (31.2%)
FIGO stage
III	79 (76.7%)	72 (82.8%)	7 (43.8%)	< 0.001
IV	24 (23.3%)	15 (17.2%)	9 (56.2%)
Histology
Serous	71 (71%)	62 (72.9%)	9 (60%)	0.097
Adenocarcinoma	8 (8%)	4 (4.7%)	4 (26.7%)
Mucinous	2 (2%)	2 (2.4%)	0
Clear cells	3 (3%)	2 (2.4%)	1 (6.7%)
Endometroid	7 (7%)	6 (7.1%)	1 (6.7%)
Undifferentiated	5 (5%)	5 (5.9%)	0
Other	4 (4%)	4 (4.7%)	0
Charlson age index
	2 (0–3)	2 (0–3)	2 (1–4)	0.40
Ascites in imaging tests
No	66 (64.1%)	59 (67.8%)	7 (43.8%)	0.06
Yes	37 (35.9%)	28 (32.2%)	9 (56.2%)
Intestinal occlusion in imaging tests
No	97 (94.2%)	83 (95.4%)	14 (87.5%)	0.21
Yes	6 (5.8%)	4 (4.6%)	2 (12.5%)
Preoperative malnutrition
No	78 (75.7%)	67 (70%)	11 (68.8%)	0.48
Yes	25 (24.3%)	20 (23%)	5 (31.2%)
Total CT scan PCI
	12 (5–18)	11 (4–15)	17 (11–25)	0.004
Categorized CT scan PCI
1–10	50 (51%)	46 (55%)	4 (25%)	0.02
11–20	36 (36%)	29 (35%)	7 (44%)
20	13 (13%)	8 (10%)	5 (31%)
Total operative PCI
	14 (7–20)	12 (5–15)	26 (21–33)	< 0.001
Categorized operative PCI
1–10	41 (40.6%)	40 (47.1%)	1 (6.2%)	< 0.001
11–20	35 (34.7%)	32 (37.6%)	3 (18.8%)
20	25 (24.8%)	13 (15.3%)	12 (75%)

*Data are presented as n (%) and median (interquartile range).